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OBJECTIVE—Regulation of obesity development is an impor-
tant issue to prevent metabolic syndromes. Gene-disrupted mice
of phospholipase Cd1( PLCd1), a key enzyme of phosphoinositide
turnover, seemed to show leanness. Here we examined whether
and how PLCd1 is involved in obesity.
RESEARCH DESIGN AND METHODS—Weight gain, insulin
sensitivity, and metabolic rate in PLCd1
2/2 mice were compared
with PLCd1
+/2 littermate mice on a high-fat diet. Thermogenic
and adipogenetic potentials of PLCd1
2/2 immortalized brown
adipocytes and adipogenesis of PLCd1-knockdown (KD) 3T3L1
cells, or PLCd1
2/2 white adipose tissue (WAT) stromal-vascular
fraction (SVF) cells, were also investigated.
RESULTS—PLCd1
2/2 mice showed marked decreases in weight
gain and mass of epididymal WAT and preserved insulin sensitivity
compared with PLCd1
+/2 mice on a high-fat diet. In addition,
PLCd1
2/2 mice have a higher metabolic rate such as higher oxy-
gen consumption and heat production. When control immortalized
brown adipocytes were treated with thermogenic inducers, ex-
pression of PLCd1 was decreased and thermogenic gene uncou-
pling protein 1 (UCP1) was upregulated to a greater extent in
PLCd1
2/2 immortalized brown adipocytes. In contrast, ectopic
expression of PLCd1i nP L C d1
2/2 brown adipocytes induced a
decrease in UCP expression, indicating that PLCd1 negatively reg-
ulates thermogenesis. Importantly, accumulation of lipid droplets
was severely decreased when PLCd1-KD 3T3L1 cells, or PLCd1
2/2
WAT SVF cells, were differentiated, whereas differentiation of
PLCd1
2/2 brown preadipocytes was promoted.
CONCLUSIONS—PLCd1 has essential roles in thermogenesis
and adipogenesis and thereby contributes to the development
of obesity. Diabetes 60:1926–1937, 2011
O
besity is a growing concern in present society
because it leads to many metabolic syndromes
that are deﬁned by visceral obesity complicated
by type 2 diabetes, hypertension, and increased
cardiovascular risk. White adipose tissue (WAT) functions
as a lipid storage, insulin sensor, and endocrine organ that
produce adipokines (1–4). An increase in the number and
size of adipocytes is a hallmark of obesity. The former
seems to be caused by proliferation and differentiation of
preadipocytes. On the other hand, the diet-induced in-
crease in cell size is characterized by adipocyte hypertro-
phy, which may be primarily caused by excessive lipid
overload and a decrease in metabolic rate.
Brown adipose tissue (BAT) is implicated in thermo-
genesis and metabolic enhancement (5). Recent reports
indicated that BAT and skeletal muscle originate from
a common precursor cell (6–9). Like skeletal muscle, BAT
playsaroleinthermogenesisbypromotingtheexpressionof
a thermogenic gene, uncoupling protein 1 (UCP1). Upregu-
lationofUCP1bygeneticmanipulationsorpharmacological
agents has been shown to reduce obesity and improve in-
sulinsensitivity(5).Otherrecentstudiesdemonstratingthat
aconsiderableamountof metabolicallyactiveBATexistsin
many adult humans have invoked an important and novel
role of BAT as an anti-obesity agent (10,11). Therefore, un-
derstanding the development or functions of WAT and BAT
is indispensable for preventing obesity.
Phosphoinositide metabolism plays crucial roles in
diverse cellular functions, including cell growth, cell mi-
gration, endocytosis, and cell differentiation (12,13). Phos-
pholipase C (PLC), a key enzyme in this system, catalyzes
the hydrolysis of phosphatidylinositol 4,5-bisphosphate,
leading to the generation of two second messengers, namely,
diacylglycerol and inositol 1,4,5-triphosphate. Diacylglycerol
stimulates protein kinase C (PKC) activation and inositol
1,4,5-triphosphate releases Ca
2+ from the intracellular stores.
Thirteen mammalian PLC isozymes have been identiﬁed and
grouped into six classes, b, g, d, ´, z,a n dh,o nt h eb a s i so f
their structure and regulatory mechanisms (14,15). Among
these classes, the d-type PLC is evolutionarily conserved
and therefore expected to have important and basic
physiological functions. We have generated d-type PLC
knockout (
2/2) mice and previously reported that PLCd1
has an essential role in skin homeostasis (16–18).
Here, we report that PLCd1
2/2 mice were protected
from diet-induced obesity and show a higher metabolic
rate. Expression of thermogenic gene UCP1 was more
enhanced in PLCd1
2/2-immortalized brown adipocytes
when cells were treated with thermogenic inducers, sug-
gesting PLCd1 has a role in thermogenesis. Furthermore,
knockdown (KD) of PLCd1 in 3T3L1 preadipocytes, or
PLCd1
2/2 WAT stromal-vascular fraction (SVF), reduced
the accumulation of lipid droplets during adipocyte dif-
ferentiation in vitro, indicating that PLCd1 is involved in
adipogenesis.
RESEARCH DESIGN AND METHODS
Mice. PLCd1
2/2 mice were generated previously and genotyped with tail by
PCR using a mixture of the following three primers: forward (59-CAAGGA-
GGTGAAGGACTTCCTG-39), reverse (59- CTGGGTCAGCATCCTGTAGAAG-39),
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ORIGINAL ARTICLEand neomycin (59- CCTGTGCTCTAGTAGCTTTACG-39) (16). Mice had ad libi-
tum access to water and either regular diet (RD) (CLEA Rodent diet CE-2; 12.6%
of calories from fat; CLEA Japan, Tokyo, Japan) or high-fat diet (HFD) (CLEA
Rodent diet Quick Fat; 30.6% of calories from fat; CLEA Japan). For diet-
induced obesity, the mice were fed with HFD from the age of 6 weeks to
27 weeks. We performed experiments with male mice.
Measurement of blood glucose, plasma insulin level, and plasma leptin.
Bloodglucosewasmeasureddirectlywithabloodglucosemeter(SanwaKagaku
Kenkyusho, Nagoya, Japan). Plasma insulin or leptin concentration was mea-
sured by an insulin ELISA kit or leptin ELISA kit (Shibayagi, Shibukawa, Japan).
For glucose tolerance tests, mice were fasted for 16 h and injected intra-
peritoneally with glucose (2 g/kg body wt). For insulin tolerance tests, mice
with ad libitum access to diets were intraperitoneally injected with human
regular insulin (0.25 or 0.75 units/kg for RD or HFD, respectively; Eli Lilly,
Indianapolis, IN).
Energy metabolism. The 24-week-old PLCd1
+/2 and PLCd1
2/2 mice fed
with RD or HFD were subjected to metabolic analysis. Indirect calorimetry
was performed with a computer-controlled open circuit calorimetry system
(Oxymax; Columbus Instruments) composed of respiratory chambers. For
measurement of oxygen consumption (VO2) and carbon dioxide production
(VCO2), mice were individually housed in respiratory chambers to accli-
mate them for 1 day before measurement. Data were recorded for 2–3d a y s .
Respiratory quotient was calculated as the VCO2 to VO2 ratio. Heat gener-
ation can also be calculated with the following expression: heat = calorie
value 3 VO2 (calorie value = 3.815 + 1.232 3 VCO2/VO2).
Western blot analysis. Western blot analysis was carried out as described
previously (18). Anti-PLCd1 antibody was developed previously (18). Anti-
UCP1 (Santa Cruz Biotechnology, Santa Cruz, CA), Tim23 (BD Biosciences,
Tokyo, Japan), heat shock protein 60 (Hsp60) (Stressgen), cytochrome c (Cell
Signaling), PKCbI (Santa Cruz Biotechnology), PKC´ (Cell Signaling,), caveolin-1
(BD Biosciences), nuclear factor of activated T (NFAT)c4 (Santa Cruz Bio-
technology), lamin B1 (Santa Cruz Biotechnology), and b-actin (Sigma,
St. Louis, MO) antibodies were purchased, respectively.
Quantitative real-time PCR. Total RNAs from tissues and cells were isolated
using an RNeasy Lipid tissue mini-kit or an RNeasy mini-kit (Qiagen, Venlo, the
Netherlands). Template cDNA was synthesized from total RNA using the
SuperScript III First-Strand Synthesis System (Invitrogen, San Diego, CA).
Quantitative real-time PCR (qRT-PCR) was performed using a Thunderbird
SYBR qPCR Mix (Toyobo, Osaka, Japan) with speciﬁc primer sets (Supple-
mentary Table 1) in a CFX96 thermocycler (Bio-Rad, München, Germany). The
relative amount of mRNA was normalized to 36B4 mRNA.
Retroviral infection. pMX-Ires Puro (IP) (19) was used to overexpress sev-
eral genes, such as PLCd1,o rSV40 large T antigen into target cells. pSUPER
retro puro (OligoEngine) was used for the expression of siRNA in target cells.
The sequences used were as follows: scrambled (59-GTAAGATGAGCTTCA-
AGGA-39), 399i (59-GGACCAGCGCAATACCCTA-39), and 468i (59-GGATAA-
CAAGATGAACTTC-39). For retrovirus preparation, indicated constructs were
transiently transfected into the packaging cell line, PLAT-E cells (19) using
Lipofectamine 2000 (Invitrogen). Target cells were maintained in a medium
containing 1.5–2 mg/mL puromycin to select bulk cell populations stably
transformed with the viruses.
Cell culture and adipocyte differentiation. 3T3L1 preadipocytes were cul-
tured in Dulbecco’sm o d i ﬁed Eagle’s medium (DMEM) with 10% calf serum. For
adipocyte differentiation, 2-day postconﬂuent cells were maintained in DMEM
containing 10% FBS, 5 mg/mL insulin, 0.3 mmol/L 3-isobutyl-1-methylxanthine
(IBMX; Sigma), and 0.25 mmol/L dexamethasone for 3 days and incubated in
DMEM with 10% FBS and 5 mg/mL insulin for an additional 4 days (20). Dif-
ferentiated adipocytes were ﬁxed with 4% paraformaldehyde and stained with
0.5% Oil Red O. For quantitative analysis, the lipid droplets were eluted with
isopropylalcohol, and the absorbance was measured at 510 nm.
Isolation of WAT SVF and in vitro differentiation. SVF was prepared as
reported previously (21). SVF cells were plated at 8 3 10
5 per well of a 24-well
plate and grown in DMEM supplemented with 10% FBS and 10 ng/mL bFGF
(R&D Systems, Minneapolis, MN). After 2 days of incubation, the cells were
incubated in differentiation medium with 10% FBS, 1 mg/mL insulin, 0.5 mmol/
L IBMX, and 0.25 mg/mL dexamethasone for 3 days and then with 10% FBS for
an additional 4 days. Fluorescence-activated cell sorting (FACS) analysis was
performed using FACSCanto (Becton Dickinson, Franklin Lakes, NJ) to deﬁne
stem cells from WAT SVF cells by staining with Ter119-FITC and CD45-APC.
Isolation of mouse immortalized brown preadipocytes. Immortalized
brown preadipocytes were obtained from interscapular BAT of newborn
PLC1
+/2 mice and PLC1
2/2 mice littermates by collagenase digestion, im-
mortalized by infection with SV40 large T antigen retrovirus, and selected by
2 mg/mL puromycin for at least 3 weeks (22). Seven immortalized brown
preadipocyte lines were established from independent littermates. For dif-
ferentiation, 2-day-conﬂuent brown preadipocytes were incubated for 3 days
in culture medium supplemented with 20 nmol/L insulin, triiodothyronine (T3;
Sigma, St. Louis, MO), 0.125 mmol/L IBMX, 0.5 mmol/L dexamethasone, and
0.5 mmol/L indomethacin. Subsequently, the cells were maintained in culture
medium supplemented with 20 nmol/L insulin and 1 nmol/L T3 for 4 days. To
stimulate thermogenesis, differentiated brown adipocytes at the same degree
were treated with 0.5 mmol/L cAMP and 0.1 mmol/L forskolin for 4 h.
Statistical analysis. Data are expressed as the mean 6 SEM. Statistical
signiﬁcance was assessed using the Student t test. A P value of , 0.05 was
considered statistically signiﬁcant.
RESULTS
PLCd1
2/2 mice showed decreased weight gain and
less accumulation of lipid droplets in metabolic tis-
sues on HFD. Because we noticed that PLCd1
2/2 mice
seem to be leaner than PLCd1
+/2 mice, we measured the
body weights of mice fed with RD or HFD from the age of
6 weeks to 20 weeks. PLCd1
2/2 mice had a decreased
body weight compared with PLCd1
+/2 littermate mice on
both RD and HFD (Fig. 1A), suggesting that the absence of
the PLCd1 gene conferred protection from obesity. De-
creased body fat mass was also observed in PLCd1
2/2
mice. The weights of epididymal WAT (eWAT) and BAT
were extremely lower in PLCd1
2/2 mice on both diets. The
weight of the liver was also lower in PLCd1
2/2 mice on
HFD, whereas those of most other tissues were almost the
same (Fig. 1B). Chronic exposure of mice to HFD causes
enlarged body mass and accumulation of lipids in eWAT,
BAT, and liver. HFD induced increased mass of eWAT
in PLCd1
+/2 mice but not in PLCd1
2/2 mice (Fig. 1C).
Moreover, BAT and liver in PLCd1
2/2 mice on HFD were
darker than those in PLCd1
+/2 mice, indicating less ac-
cumulation of lipid in these tissues (Fig. 1D and E).
Hematoxylin/eosin staining revealed that adipocyte sizes
of eWAT and BAT were extremely smaller in PLCd1
2/2
mice than in PLCd1
+/2 mice on HFD (Fig. 1F and G). All
these data suggest that the absence of the PLCd1 gene
prevents obesity.
Improved glucose tolerance and increased systemic
insulin sensitivity in PLCd1
2/2 mice fed with HFD.
Excessive lipid accumulation and hypertrophy in adipose
tissues cause insulin resistance, which leads to a com-
pensatory increase in insulin secretion and a decrease
in glucose uptake (1–4). Chronic exposure to HFD re-
markably increased blood glucose and plasma insulin
levels in the fasting state in PLCd1
+/2 mice (Fig. 2A and B).
However, these increases were not observed in PLCd1
2/2
mice, demonstrating that PLCd1
2/2 mice might be pro-
tected from HFD-induced insulin resistance. Intraperi-
toneal injection of glucose induced comparable levels
of increase in blood glucose in both PLCd1
+/2 and
PLCd1
2/2 mice on RD; however, PLCd1
2/2 mice were
more glucose tolerant than PLCd1
+/2 mice on HFD (Fig.
2C). Similarly, PLCd1
2/2 mice fed with HFD were more
sensitive to intraperitoneal injection of insulin compared
with PLCd1
+/2 mice in the insulin tolerance test (Fig. 2D).
Plasma leptin was signiﬁcantly lower in PLCd1
2/2 mice
(Fig. 2E).
Enhanced metabolic rate in PLCd1
2/2 mice. Obesity is
primarily caused by an excess food intake relative to energy
expenditure. PLCd1
2/2 mice had similar food intake com-
pared with PLCd1
+/2 mice on either RD or HFD (Fig. 3A).
We then examined whether PLCd1
2/2 mice would have
a higher energy expenditure. PLCd1
2/2 mice showed a sig-
niﬁcant increase in oxygen consumption and heat pro-
duction compared with PLCd1
+/2 mice (Fig. 3B). This result
indicates that PLCd1
2/2 mice have a higher energy expen-
diture and therefore a higher metabolic rate. Because these
enhancements were observed throughout the light and dark
M. HIRATA AND ASSOCIATES
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respiratory quotient was also examined as a measure of
fuel-partitioning patterns. No signiﬁcant differences were
observed between PLCd1
+/2 and PLCd1
2/2 mice either on
RD or HFD (Fig. 3B).
PLCd1 is highly expressed in WAT and BAT among
metabolic tissues. Because WAT, BAT, liver, and skele-
tal muscle are involved in energy metabolism, we examined
the expression pattern of PLCd1 among these meta-
bolic tissues. qRT-PCR analysis showed that the rela-
tive expression level of PLCd1 w a sv e r yh i g hi nW A T
and BAT, low in muscles, and very low in the liver
(Supplementary Fig. 1). This tissue-speciﬁce x p r e s s i o n
suggests that PLCd1 possibly contributes to the patho-
genesis of obesity-related metabolic disorders in adipose
tissues.
FIG. 1. PLCd1
2/2 mice are resistant to diet-induced obesity. A: Change in body weight of PLCd1
+/2 (+/2) mice fed ad libitum with RD (n = 16) or
HFD (n = 15) or PLCd1
2/2 (2/2) mice fed RD (n = 13) or HFD (n = 15). B: Weight of various tissues from 24-week-old PLCd1
+/2 mice fed RD (n =3 )
or HFD (n =9 )o rPLCd1
2/2 mice fed RD (n = 7) or HFD for 18 weeks (n = 8). Tissue dissection of eWAT (C), BAT (D), and liver (E) from 24-week-
old PLCd1
+/2 or PLCd1
2/2 mice fed HFD. F: Representative hematoxylin/eosin–stained sections of eWAT, BAT, and liver from 24-week-old PLCd1
+/2
or PLCd1
2/2 mice fed HFD. Scale bar, 50 mm. G: Distribution of adipocyte cell size in eWAT of PLCd1
+/2 or PLCd1
2/2 mice fed RD or HFD (n =3 ) .C e l l
diameter was measured. Values are expressed as the mean 6 SEM. *P < 0.05, **P < 0.005. (A high-quality digital representation of this ﬁgure is
available in the online issue.)
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2/2 adipose tissues
shows improved glucose and fat metabolism on HFD.
Given that we observed inhibition of WAT hypertrophy,
better glucose tolerance, and increased insulin sen-
sitivity in PLCd1
2/2 mice, we examined the expression
patterns of genes related to energy metabolism in WAT
from mice aged 8 and 24 weeks on HFD by qRT-PCR
analysis (Fig. 4A and Supplementary Fig. 2A). In 24-
week-old PLCd1
2/2 mice, the expression of peroxisome
proliferator–activated receptor g (PPARg)w a si n -
creased, whereas p21,w h i c hi sr e l a t e dt oW A Th y p e r -
trophy (23), was extremely reduced compared with
PLCd1
+/2 mice. The expression of genes related to glu-
cose uptake, including glucose transporter 4 (GLUT4),
Krüppel-like zinc ﬁnger transcription factor (KLF15),
and adiponectin, which is correlated with insulin sensi-
tivity (20,24), was enhanced. On the other hand, the ex-
pression of genes related to insulin resistance, such as
tumor necrosis factor (TNFa) and heparin-binding epi-
dermal growth factor (HB-EGF)-like growth factor
(1,2,25), was decreased in PLCd1
2/2 mice.
In BAT of PLCd1
2/2 mice at both ages 8 and 24 weeks,
the expression of thermogenic genes UCP1 and PPARg
coactivator 1a (PGC1a) (5,6) was increased (Fig. 4B). The
expression of fatty acid synthase (Fasn) and adrenergic
receptor b3( Adrb3) was also enhanced in BAT of PLCd1
2/2
mice (Supplementary Fig. 2B). These data, along with the
gross appearance of BAT (Fig. 1D) ,s u g g e s tt h a tt h e
FIG. 2. Improved glucose tolerance and increased insulin sensitivity in PLCd1
2/2 mice fed HFD. A: Blood glucose levels in PLCd1
+/2 mice fed RD
(n = 9) or HFD (n =9 )o rPLCd1
2/2 mice fed RD (n = 11) or HFD for 18 weeks (n = 8) and then fasted for 16 h before measurement. B: Plasma
insulin levels in PLCd1
+/2 mice fed RD (n = 8) or HFD (n =6 )o rPLCd1
2/2 mice fed RD (n = 7) or HFD (n = 5) and then fasted for 16 h before
measurement. C: Glucose tolerance test. Blood glucose levels after 16 h of fasting of PLCd1
+/2 mice fed RD (n = 9) or HFD (n =9 )o rPLCd1
2/2
mice fed RD (n = 11) or HFD (n = 8) were measured at the indicated times after intraperitoneal injection with glucose. D: Insulin tolerance test.
Blood glucose levels in PLCd1
+/2 mice fed RD (n = 9) or HFD (n =9 )o rPLCd1
2/2 mice fed RD (n = 11) or HFD (n = 8) were measured at the
indicated times after intraperitoneal injection with insulin. The level in time 0 is deﬁned as 100%, and relative values are expressed. E: Plasma
leptin levels in PLCd1
+/2 mice fed RD (n =8 )o rH F D( n=6 )o rPLCd1
2/2 mice fed RD (n = 7) or HFD (n = 5) and then fasted for 16 h before
measurement. Values are expressed as the mean 6 SEM. *P < 0.05, **P < 0.005.
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2/2 mice,
even after long-term HFD feeding.
In the liver of PLCd1
2/2 mice, decreases in expres-
sion of genes related to glucose and lipid metabolism,
such as acyl-CoA oxidase 1 (Acox1), carnitine palmitoyl
transferase 1a (Cpt1a), glucokinase, and acyl-CoA de-
hydrogenase medium chain (Acadm), were observed at
the age of 24 weeks (Fig. 4C and Supplementary Fig. 2C).
Although these results are consistent with the observa-
tion that PLCd1
2/2 mice are resistant to liver adipos-
ity (Fig. 1E), it may be an adipose tissue–dependent
secondary effect, because PLCd1 is not expressed in
the liver (Supplementary Fig. 1). Little change in gene
expression was observed in muscles of PLCd1
2/2 mice
(Fig. 4D).
Hairlessness of PLCd1
2/2 mice affects enhanced
metabolic rate. We have reported that PLCd1
2/2 mice
have a hair defect (16). Because there are limited data on
the effect of hairlessness on metabolic rate, we studied
this relationship using nude mice and C57BL/6 mice with
hair removed. As shown in Supplementary Fig. 3, nude
mice and mice with hair removed showed increases in
oxygen consumption and heat production compared with
control mice, indicating that hairlessness at least partially
affects metabolic rate through the change in thermo-
genesis.
FIG. 3. Enhanced metabolic rate in PLCd1
2/2 mice. A: Food intake was measured in 10-week-old PLCd1
+/2 mice or PLCd1
2/2 mice fed RD (n =5 )o r
HFD (n =5 ) .B: Oxygen consumption (VO2) and carbon dioxide production (VCO2) was measured by using an indirect calorimeter system in
PLCd1
+/2 mice fed RD (n = 8) or HFD (n =7 )o rPLCd1
2/2 mice fed RD (n = 8) or HFD (n = 6). We show VO2 values as mL/mouse/h, since there is no
consensus on how energy expenditure is normalized (41). Respiratory quotient (RQ) and heat production were calculated from VO2 and VCO2.
Values are expressed as the mean 6 SEM.
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A more important question is whether PLCd1 is directly
involved in thermogenesis. We ﬁrst compared the UCP1
expression in BAT mitochondria from 27-week-old mice
fed HFD. The protein levels of UCP1 as well as Tim23,
an inner mitochondrial membrane protein, and heat shock
protein (HSP)-60 were extremely enhanced in BAT of
PLCd1
2/2 mice (Fig. 5A). Amount of mitochondrial DNA
was also increased in PLCd1
2/2 mice (Supplementary Fig.
3). We next examined the change in expression of PLCd1
mRNA in BAT from PLCd1
+/2 mice placed in cold sur-
roundings (4°C) for 3 h. As predicted, the expression levels
FIG. 4. Gene expression patterns of PLCd1
2/2 adipose tissues show improved glucose and lipid metabolism on HFD. A: PPARg2, p21, aP2, GLUT4,
KLF15, adiponectin, TNFa, and HB-EGF mRNA levels in eWAT of 8-week-old PLCd1
+/2 mice (n =7 )o rPLCd1
2/2 mice (n = 11), or 24-week-old
PLCd1
+/2 mice (n =9 )o rPLCd1
2/2 mice (n = 8) were detected by qRT-PCR. B: PPARg2, UCP1, PGC1a,a n dAcadm mRNA levels in BAT of 8-week-
old PLCd1
+/2 mice (n =9 )o rPLCd1
2/2 mice (n = 11), or 24-week-old PLCd1
+/2 mice (n =9 )o rPLCd1
2/2 mice (n = 8) were detected. C: Acox1,
Cpt1a, glucokinase, and Acadm mRNA levels in the liver of 8-week-old PLCd1
+/2 mice (n = 10) or PLCd1
2/2 mice (n = 6), or 24-week-old PLCd1
+/2
mice (n =6 )o rPLCd1
2/2 mice (n = 5) were detected. D: UCP3, Acox1, and Acadm mRNA levels in gastrocnemial muscles of 8-week-old PLCd1
+/2
mice (n = 10) or PLCd1
2/2 mice (n = 6), or 24-week-old PLCd1
+/2 mice (n =6 )o rPLCd1
2/2 mice (n = 5) were detected. Values are normalized
to 36B4 as an internal control. The quantity in 8-week-old PLCd1
+/2 mice is deﬁned as 1.0, and relative values are expressed as the mean 6 SEM.
*P < 0.05, **P < 0.005.
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+/2 mice
(n =3 )o rPLCd1
2/2 mice (n = 3) fed with HFD were examined by Western blot analysis. BAT mitochondria were isolated by a Mitochondria
Isolation Kit for Tissue (Thermo Scientiﬁc, Waltham, MA). Cytochrome c was used as the loading control. B: PLCd1 mRNA expression is decreased
in BAT of cold-exposed mice. Expression levels of UCP1, DIO2, PGC1a,a n dPLCd1 in BAT before (RT) or after cold exposure (4°C) of 10-week-old
PLCd1
+/2 mice fed RD (n = 3) for 3 h were analyzed by qRT-PCR. C: Expression levels of UCP1 and PLCd1 in immortalized brown adipocytes after
induction of thermogenesis were analyzed by qRT-PCR. Differentiated PLCd1
+/2 or PLCd1
2/2 immortalized brown adipocytes were treated with
(+) or without (2) cAMP and forskolin for 4 h. D: Ectopic expression of PLCd1 downregulated the expression of UCP1 induced by thermogenesis.
PLCd1
2/2 immortalized brown adipocytes were infected with PLCd1 retrovirus (
2/2+PLCd1) or vector retrovirus (
+/2 or
2/2), and the UCP1 ex-
pression levels induced by thermogenesis with forkolin were examined. Expression of PLCd1 was conﬁrmed by Western blotting. b-Actin was used
as the loading control. E: Expression levels of UCP1, PGC1a, PPARg, C/EBPa, PRDM16, and CPT1b in immortalized brown preadipocytes after
differentiation were measured by qRT-PCR. Values are normalized to 36B4 as an internal control. The quantity in BAT before cold exposure of
10-week-old PLCd1
+/2 mice (B) or differentiated PLCd1
+/2 immortalized brown adipocytes (C and E)i sd e ﬁned as 1.0, and relative values are
expressed as the mean 6 SEM. *P < 0.05.
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type II (DIO2), and PGC1a in BAT were increased by cold
exposure (5,6,26,27) (Fig. 5B). In contrast, interestingly,
the expression level of PLCd1 in BAT of PLCd1
+/2 mice
was decreased by cold exposure (Fig. 5B), strongly sug-
gesting that PLCd1 has a role in cold exposure–induced
thermogenesis.
Similar results were obtained by using immortalized brown
preadipocytes. Immortalized brown preadipocytes from
PLCd1
+/2 and PLCd1
2/2 mice littermates were developed,
differentiated, and then treated with cAMP and forskolin
to induce thermogenesis (27). It is worth noting that the
increase in UCP1 expression is more remarkable in
PLCd1
2/2 immortalized brown adipocytes than in PLCd1
+/2
adipocytes (Fig. 5C) and that this phenomenon is in-
dependent from hairlessness. With an inverse correlation,
the expression of PLCd1 was reduced by induction of
thermogenesis. Furthermore, the enhancement of UCP1
expression in PLCd1
2/2 adipocytes induced by thermo-
genesis was canceled by ectopic expression of PLCd1 in
PLCd1
2/2 immortalized brown adipocytes (Fig. 5D). These
results clearly indicate that PLCd1 is especially involved in
adaptive thermogenesis in BAT and immortalized brown
adipocytes and thereby in energy expenditure.
PLCd1 inhibits differentiation of immortalized brown
preadipocytes. We next tried to examine the involvement
of PLCd1 in brown adipocyte differentiation in vitro. The
expression of UCP1 and PGC1a after differentiation was
remarkably enhanced in PLCd1
2/2 adipocytes (Fig. 5E).
The expression of PPARg, PR domain containing 16
(PRDM16), and Cpt1b was also increased in PLCd1
2/2
adipocytes. These data suggest that PLCd1 is negatively
involved in the regulation of UCP1 or PGC1a expression in
differentiation.
PLCd1 positively regulates differentiation of 3T3L1
preadipocyte and WAT SVF cells. We next examined
the effect of PLCd1 on differentiation of WAT in vitro. Two
sequence segments of PLCd1 for RNA interference effec-
tively reduced PLCd1 expression in 3T3L1 preadipocytes
by infection of the retrovirus (Fig. 6A). In PLCd1-KD
3T3L1 adipocytes, the accumulation of lipid droplets was
largely inhibited compared with cells infected by control
retrovirus (Fig. 6B). In contrast, when PLCd1 was ectopi-
cally expressed into 3T3L1 preadipocytes by the retrovirus
(Fig. 6C), lipid accumulation after the induction of adipo-
cyte differentiation was promoted (Fig. 6D), indicating that
PLCd1 positively regulates the differentiation of 3T3L1
preadipocytes.
We next examined the gene expression patterns during
differentiation of PLCd1KD 3T3L1 preadipocytes (Fig. 6E).
Although expression levels of early differentiation genes,
such as C/EBPd and C/EBPb, seemed to be similar be-
tween control and PLCd1KD 3T3L1 preadipocytes, the
expression levels of PPARg and C/EBPa were markedly
decreased in PLCd1KD 3T3L1 preadipocytes at days 3
and 6 after differential induction. Similarly, remarkable
decreases in expression of KLF15, GLUT4, aP2,a n d
resistin were detected. These data suggest that PLCd1
has important roles in the differentiation of 3T3L1 pre-
adipocytes around from the early stage to the middle
stage.
We further examined the effect of PLCd1 on adipo-
genesis using WAT SVF from mice. SVF is considered to be
an enriched fraction of stem cells in WAT (21). SVF was
ﬁrst isolated and then differentiated into adipocytes. In-
terestingly, lipid accumulation in PLCd1
2/2 WAT SVF was
reduced to less than half of that in PLCd1
+/2 SVF (Fig. 6F).
FACS analysis indicated that the cell number of WAT SVF
and population of lineage-negative (Ter119
–, CD45
–) cells
in WAT SVF were almost the same between PLCd1
2/2
and PLCd1
+/2 WAT SVF, indicating that the reduced lipid
accumulation of PLCd1
2/2 WAT SVF was caused by the
differentiation potential, but not the number of lineage-
negative cells. Taken together, these results indicate that
PLCd1 positively regulates both adipogenesis and hyper-
trophic lipid accumulation in WAT model culture cells.
Impaired WAT development at the early postnatal
stage of PLCd1
2/2 mice. We further tried to examine the
role of PLCd1 in WAT development in mice. To exclude the
effect of hairlessness of PLCd1
2/2 mice, we analyzed mice
at 6 days of age, before hair growth. Even as early as 6
days of age, inguinal WAT mass was signiﬁcantly de-
creased in PLCd1
2/2 mice (Fig. 7A). We also detected the
decreases in the expression of C/EBPb, PPARg, C/EBPa,
KLF15, aP2, GLUT4, and lipoprotein lipase (LPL) in in-
guinal WAT of PLCd1
2/2 mice compared with those of
PLCd1
+/2 mice. These expression proﬁles are generally
consistent with those of 3T3L1 cells, indicating that PLCd1
is involved in adipose development and has functional
roles in adipose tissues in mice.
PKCbI, PKC«, and NFATc4 are downstream targets
of PKCd1 in adipocyte differentiation. To provide
mechanisms downstream of PLCd1 in differentiation of
adipocytes, we focused on PKC and NFAT, which are
targets of the second messengers diacylglycerol and/or
inositol 1,4,5-triphosphate/calcium. Among PKC isozymes,
PKCb—a conventional type of PKC—was reported to be
involved in adipocyte differentiation (28), and PKCbKO
mice were leaner and more resistant to HFD-induced
obesity (29). When PKCb is activated, PKCb is trans-
located from the cytosol to the plasma membrane (28). An
increase in PKCbI expression at the plasma membrane
was signiﬁcantly observed at 48 h after the induction in
control 3T3L1 adipocytes, whereas this increase was less
detected in PLCd1KD adipocytes (Fig. 8A). In addition,
PKC´—a novel type of PKC—began to be expressed in the
nuclei and is required for adipocyte differentiation (30,31),
and functional ablation of PKC´ in mice show improved
glucose homeostasis in models of type 2 diabetes (32).
PKC´ expression was increased in the nuclei of control
3T3L1 cells, but not in PLCd1KD cells at 48 h after the
induction (Fig. 8B).
Mice with the NFATc2/NFATc4 gene disruption exhibit
defects in fat accumulation and are protected from diet-
induced obesity (33). Immunostaining indicated that NFATc4
expressions were induced in control 3T3L1 adipocytes,
whereas they were less induced in PLCd1KD adipocytes
(Fig. 8C). Taken together, we identiﬁed for the ﬁrst time
PKCbI, PKC´, and NFATc4 as downstream molecules of
PLCd1 in adipogenesis of 3T3L1 cells.
DISCUSSION
Phosphoinositol (PI) 3-kinase–mediated phosphorylation
of insulin receptor substrate or Akt is essential for GLUT4
translocation and glucose uptake (34–36). Therefore, we
predicted that PLCd1 is directly involved in insulin sig-
naling. However, we have not found any relation between
PLCd1 and PI 3-kinase, such as increased phosphorylation
of Akt in WAT of PLCd1
2/2 mice. Therefore, the enhanced
insulin sensitivity observed in PLCd1
2/2 mice may be
explained by the condition of less obesity.
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diabetes.diabetesjournals.org DIABETES, VOL. 60, JULY 2011 1933FIG. 6. PLCd1 directly regulates adipocyte differentiation. A and B: PLCd1KD in 3T3L1 cells inhibits adipogenesis. 3T3L1 cells were infected with
PLCd1 RNAi retrovirus (399i or 468i) or control retrovirus (Scrambled), and the expression levels of PLCd1 were determined by Western blotting
(A). b-Actin was used as loading control. Differentiated adipocytes were stained with Oil Red O. Oil Red O extracted with isopropanol was
measured at OD510. C and D: Ectopic expression of PLCd1 promotes adipogenesis. 3T3L1 cells were infected with PLCd1 retrovirus (PLCd1) or
vector retrovirus (Mock), and the PLCd1 expression levels were conﬁrmed by Western blotting (C). Adipocyte differentiation was induced, and
lipid droplets were stained with Oil Red O. E: Expression levels of adipogenesis-related gene in scrambled and PLCd1KD (399i) 3T3L1 cells during
the differentiation (days 0, 1, 3, and 6) were measured by qRT-PCR. Values are normalized to 36B4 as an internal control. The quantity of
scrambled cells (differentiation day 0) is deﬁned as 1.0. F: PLCd1
2/2 WAT SVF showed impaired lipid accumulation. SVF was isolated and then
differentiated. Lipid accumulation was veriﬁed by Oil Red O staining and quantiﬁed by extraction with isopropanol. G: Lineage negative (Ter119
–/
CD45
–, green areas) population in PLCd1
2/2 WAT SVF was compared with that in PLCd1
+/2 WAT SVF by FACS analysis (the former is 77.2 6 0.4%
and the latter is 73.0 6 3.2%). Relative values are expressed as the mean 6 SEM. *P < 0.05, **P < 0.005. (A high-quality digital representation of
this ﬁgure is available in the online issue.)
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lation of UCP1 and DIO2 in BAT is essential for adaptive
thermogenesis to maintain body temperature; cold-
exposed DIO2
2/2 mice became hypothermic because of
impaired BAT thermogenesis (26). UCP1
2/2 mice are also
cold sensitive and show temperature-dependent obesity
(37,38). It is noteworthy that PLCd1 expression had dra-
matically decreased in BAT from mice exposed to cold and
immortalized brown preadipocytes treated with thermo-
genic inducers, and it showed an inverse correlation with
the upregulation of thermogenic genes such as UCP1 and
PGC1a (Fig. 5B–D). These observations indicate that
PLCd1 participated in adaptive thermogenesis mediated by
UCP1 and PGC1a in a physiological manner.
In vitro analysis further conﬁrmed that PLCd1 regulates
adipogenesis. We indicated that PLCd1 negatively regu-
lates UCP1 or PGC1a expression during differentiation of
brown adipocytes (Fig. 5E), whereas PLCd1 positively
regulates differentiation of preadipocytes in WAT culture
cells (Fig. 6B, E,a n dF). The opposing regulation of PLCd1
in the WAT and BAT models seems interesting. Detailed
future works could provide insights into the mechanism of
differentiation decision or conversion between WAT and
BAT.
A similar gene expression pattern with 3T3L1 cells was
observed in inguinal WAT of 6-day-old PLCd1
2/2 mice, at
which age the effect of hair is negligible. This result shows
that PLCd1 is involved in adipose development in adipose
tissues in mouse pups. On the other hand, the elevation
of PPARg, GLUT4,o rKLF15, and reduced expression of
genes related to WAT hypertrophy or insulin resistance
in the case of 24-week-old PLCd1
2/2 mice fed with HFD
(Fig. 4A), indicate that PLCd1
2/2 WAT sustains normal
adipose functions, even under diet-induced hypertrophic
conditions. A similar observation was reported in IkBk i -
nase ´ (IKK«)
2/2 mice. IKK positively regulates the nuclear
factor (NF)-kB pathway by phosphorylation and release of
inhibitory IkB from NFkB. IKK«
2/2 mice are protected
from diet-induced obesity and show increased expression
of PPARg, GLUT4,o radiponectin in WAT, as well as
enhanced energy expenditure at the age of 22–26 weeks
(39). Because NFkB is a downstream effector of PLC,
a relationship between PLCd1 and NFkB would be pre-
dicted. It is noteworthy to identify NFATc4, as well as
PKCbI and PKC´, as downstream molecules of PLCd1.
PLCd1 was recently reported to act as an anti-oncogene
and regulate the expression of p21 in esophageal squa-
mous cell carcinoma (40). Taken together with these
reports, our results indicate the possibility that the loss of
PLCd1 in WAT induces a decrease in p21 expression and
inhibits the development of hypertrophy. Reduced hyper-
trophy development in turn results in a decrease in ex-
pression of insulin resistance–inducing genes, TNFa,o r
HB-EGF and increases in expression of the insulin-sensitive
gene adiponectin.
Here, we show for the ﬁrst time that PLCd1 contributes
to thermogenesis and adipogenesis, and thereby in de-
veloping obesity. It is important to further elucidate how
PLCd1 participates in these various pathways, since obe-
sity is an important issue in present society.
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